VALIO ZERO LACTOSE™ – LACTOSE FREE
DAIRY PRODUCTS, GENUINE DAIRY TASTE

Valio has developed methods to separate lactose from milk totally. Patented Valio Zero LactoseTM technology makes it possible to manufacture a milk drink that contains no lactose but still tastes exactly like normal milk. The technology is based on membrane processing and enzymatic hydrolysis.

Valio released its lactose free milk drink in Finland in 2001 and has since launched the Laktosfri™ brand in Sweden, Valio Zero LactoseTM products in Belgium, France, the Baltic States and Russia. The first licensed product was launched in Switzerland at the end of 2003. Licensed products are also available in Spain, South Korea and Norway.

LGG® – the world’s best
documented probiotic

Lactobacillus rhamnosus GG – Valio trademark LGG® – is the world’s best documented probiotic strain. Proven to survive in and colonise the human gastrointestinal tract, this remarkable bacterium protects the body against infections and imbalances.

Lactobacillus GG was isolated in 1983 by professors Gorbach and Goldin and is now one of the world’s most researched probiotics. Valio acquired an exclusive worldwide license to the strain in 1987 and launched the world’s first LGG® products in 1990. Valio has used LGG® in its Valio Gefilus® range of products since 1990 and now offers a wide variety of LGG® buttermilks, yoghurts, milk, fruit drinks, shot drinks and fermented whey-based drinks.

Valio grants rights to Lactobacillus rhamnosus GG (ATCC53103) to other dairy companies and the network presently covers almost 40 markets and territories.

The LGG® logo and Gefilus® are registered trademarks of Valio Ltd. LGG® is a registered trademark of Valio Ltd and the registration implies that Valio Ltd has sole right to the trademark LGG®.

Evolus® for cardiovascular health

Evolus® was developed by Valio as a unique fermented milk drink that helps to control blood pressure and was launched in Finland in 2000. The health effect is based on bioactive peptides formed during fermentation. Several clinical studies show the product’s efficacy in controlling blood pressure.

Valio has licensed Evolus® technology to its European partners and a licensed product is available in Spain.